Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

AMG 386 (Trebananib) in Ovarian Cancer (TRINOVA-2)

This study has been terminated.
(Closure of long term follow up (LTFU) and study earlier than previously outlined in the protocol as no beneficial information gained from continuing LTFU.)
Information provided by (Responsible Party):
Amgen Identifier:
First received: January 20, 2011
Last updated: May 2, 2017
Last verified: April 2017
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: April 19, 2017
  Primary Completion Date: August 29, 2014 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: April 23, 2015